Skip to Main content Skip to Navigation
Journal articles

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

Complete list of metadatas

https://www.hal.inserm.fr/inserm-02532895
Contributor : Angélique Gougelet <>
Submitted on : Monday, April 6, 2020 - 10:09:17 AM
Last modification on : Thursday, April 9, 2020 - 11:55:30 AM

Identifiers

Collections

Citation

André Lechel, Angélique Gougelet. Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?. Gut, BMJ Publishing Group, 2016, 65 (7), pp.1073-1074. ⟨10.1136/gutjnl-2016-311446⟩. ⟨inserm-02532895⟩

Share

Metrics

Record views

14